Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 42.6% in December

Venus Concept Inc. (NASDAQ:VERO) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 55,500 shares, a decline of 42.6% from the December 15th total of 96,700 shares. Approximately 1.3% of the company’s shares are sold short. Based on an average trading volume of 946,700 shares, the days-to-cover ratio is currently 0.1 days.

Venus Concept Price Performance

Venus Concept stock opened at $0.36 on Tuesday. Venus Concept has a one year low of $0.28 and a one year high of $2.22. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18. The stock’s 50 day moving average is $0.35 and its 200 day moving average is $0.50. The firm has a market cap of $2.61 million, a P/E ratio of -0.04 and a beta of 0.47.

Hedge Funds Weigh In On Venus Concept

A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC raised its holdings in Venus Concept Inc. (NASDAQ:VERO) by 100.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 666,702 shares of the company’s stock after buying an additional 333,366 shares during the quarter. Masters Capital Management LLC owned 10.49% of Venus Concept worth $522,000 as of its most recent SEC filing. Institutional investors own 87.41% of the company’s stock.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.